×
About 55 results

ALLMedicine™ Adenocarcinoma Of The Appendix Center

Research & Reviews  22 results

Mucinous Adenocarcinoma of the Appendix With Histologic Response to Neoadjuvant Chemoth...
https://doi.org/10.46883/ONC.2021.3506.0335
Oncology (Williston Park, N.Y.); Copur M, Cushman-Vokoun A et. al.

Jun 24th, 2021 - Appendiceal mucinous neoplasms are a rare and heterogeneous group of diseases with challenging clinical management decisions. They account for less than 1% of all cancers but their incidence is on the rise. Treatment is based on their stage and hi...

Is adjuvant chemotherapy beneficial for stage II-III goblet cell carcinoid/goblet cell ...
https://doi.org/10.1016/j.suronc.2020.12.003
Surgical Oncology; Zakka K, Williamson S et. al.

Dec 29th, 2020 - Goblet cell carcinoma (GCC), formerly known as goblet cell carcinoid, of the appendix constitutes less than 14% of all primary appendiceal neoplasms. Surgical resection is the main treatment and the role of adjuvant chemotherapy (AC) is not establ...

Late stage diagnosis of mucinous adenocarcinoma of the appendix: a case report of an un...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441642
BMC Gastroenterology; Roma K, Baldwin M et. al.

Aug 23rd, 2020 - The incidence of mucinous appendiceal adenocarcinomas (MAA) has increased over the past three decades. Advanced stage tumor diagnosis is likely attributable to non-specific findings. Here we describe advanced stage appendiceal MAA presenting as in...

see more →